Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food

Details for Australian Patent Application No. 2004261522 (hide)

Owner Calpis Co., Ltd.

Inventors Nishimura, Shingo; Yamamoto, Naoyuki; Gotou, Takanobu; Matsuura, Keiichi; Mizuno, Seiichi

Agent Davies Collison Cave

Pub. Number AU-B-2004261522

PCT Pub. Number WO2005/012334

Priority 2003-285007 01.08.03 JP

Filing date 30 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 16 September 2010

International Classifications

A23L 1/305 (2006.01) Foods or foodstuffs - Amino acids, peptides or proteins

A61K 38/01 (2006.01) Medicinal preparations containing peptides - Hydrolysed proteins

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/062 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/068 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/072 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/083 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/012334 Priority application(s): WO2005/012334

16 September 2010 Application Accepted

  Published as AU-B-2004261522

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261527-Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same

2004261491-8-chloro-2,3-benzodiazepine derivatives